Market Tracker

08/29 5:44am ET

Pharmacyclics Inc (NASDAQ:PCYC)

123.95
Data as of Aug 28
 +0.89 / +0.72%
Today’s Change
82.51
Today|||52-Week Range
154.89
+17.18%
Year-to-Date
No recent news for Pharmacyclics Inc.

Today’s Trading

Previous close123.06
Today’s open122.61
Day’s range-- - --
Volume524,767
Average volume (3 months)1,074,981
Market cap$9.3B
Dividend yield--
Data as of 08/28/2014

Growth & Valuation

Earnings growth (last year)+411.76%
Earnings growth (this year)-42.66%
Earnings growth (next 5 years)+63.50%
Revenue growth (last year)+217.32%
P/E ratio110.7
Price/Sales29.59
Price/Book14.54

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp-0.77-1.41%
HSPHospira Inc-0.02-0.04%
MNKMallinckrodt Plc+1.82+2.32%
JAZZJazz Pharmaceuticals...-0.40-0.25%
Data as of 08/28/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)$0.38
Annual revenue (last year)$260.2M
Annual profit (last year)$67.0M
Net profit margin25.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert W. Duggan
Chief Operating Officer
Mahkam Zanganeh
Corporate headquarters
Sunnyvale, California

Forecasts